Irinotecan
- IVIrinotecanCamptosar
Mechanism of Action
- Inhibits the activity of topoisomerase I, which is normally responsible for repairing DNA damage resulting from torsional strain.
Clinical Use
Indications
- Certain solid organ organ malignancies, as guided by cancer specialists and local guidelines.
- Adverse Effects
- Neutropaenia
- Anaemia
- Dyspnoea
- Nausea / vomiting
- Cholinergic effects - lacrimation, sweating, diarrhoea